In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma.
Cardama GA, Bucci PL, Lemos JS, Llavona C, Benavente MA, Hellmén E, Fara ML, Medrano E, Spitzer E, Demarco IA, Sabella P, Garona J, Alonso DF.
Cardama GA, et al. Among authors: sabella p.
Animals (Basel). 2023 Aug 3;13(15):2507. doi: 10.3390/ani13152507.
Animals (Basel). 2023.
PMID: 37570315
Free PMC article.